BriaCell Therapeutics Corp. (BCTX)

NASDAQ: BCTX · IEX Real-Time Price · USD

2.240

+0.050 (2.28%)

At close: Apr 25, 2024, 3:59 PM

2.320

+0.080 (3.57%)

After-hours: Apr 25, 2024, 6:25 PM EDT

BriaCell Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Year	2023	2022	2021	2020	2019	2018
Net Income	-20.3	-26.84	-13.82	-3.1	-3.63	-4.17
Depreciation & Amortization	0.02	0.02	0.02	0.01	0.01	0.01
Share-Based Compensation	2.19	3.07	1.97	0	0.04	0.37
Other Operating Activities	-5.65	11.26	4.08	2.11	0.39	-0.03
Operating Cash Flow	-23.74	-12.48	-7.75	-0.97	-3.19	-3.82
Change in Investments	0	0	0	0	0.84	-0.46
Investing Cash Flow	0	0	0	0	0.84	-0.46
Share Issuance / Repurchase	3.95	-3.66	65.33	0.89	1.95	3.56
Debt Issued / Paid	0	0	-0.33	0.02	-0.07	0.52
Other Financing Activities	-	-0.08	-	-	-	-
Financing Cash Flow	3.95	-3.74	65	0.9	1.88	4.07
Exchange Rate Effect	0	0	0	0	0	-0.05
Net Cash Flow	-19.79	-16.23	57.25	-0.07	-0.48	-0.2
Free Cash Flow	-23.74	-12.48	-7.75	-0.97	-3.19	-3.82
Free Cash Flow Per Share	-1.52	-0.81	-1.72	-1.36	-5.51	-8.93

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).